Does Clinical Decision Support Increase Appropriate Medication Prescribing for Cardiovascular Risk Reduction?

J Am Board Fam Med. 2023 Oct 11;36(5):777-788. doi: 10.3122/jabfm.2022.220391R2. Epub 2023 Sep 13.

Abstract

Purpose: To assess the impact of a clinical decision support (CDS) system's recommendations on prescribing patterns targeting cardiovascular disease (CVD) when the recommendations are prioritized in order from greatest to least benefit toward overall CVD risk reduction.

Methods: Secondary analysis of trial data from September 20, 2018, to March 15, 2020, where 70 community health center clinics were cluster-randomized to the CDS intervention (42 clinics; 8 organizations) or control group (28 clinics; 7 organizations). Included patients were medication-naïve and aged 40 to 75 years with ≥1 uncontrolled cardiovascular disease risk factor, with known diabetes or cardiovascular disease, or ≥10% 10-year reversible CVD risk.

Results: Among eligible encounters with 29,771 patients, the probability of prescribing a medication targeting hypertension was greater at intervention clinic encounters when CDS was used (34.9% [95% CI, 31.5 to 38.3]) versus dismissed (29.6% [95% CI, 26.7 to 32.6]; P < .001), but not when compared with control clinic encounters (34.9% [95% CI, 31.1 to 38.7]; P = .998). Prescribing for dyslipidemia was significantly higher at intervention encounters where the CDS system was used (11.3% [95% CI, 9.3 to 13.3]) compared with dismissed (7.7% [95% CI, 6.1 to 9.3]; P = .003) and to control encounters (8.7% [95% CI, 7.0 to 10.4]; P = .044); smoking cessation medication showed a similar pattern. Except for dyslipidemia, prescribing rates increased according to their prioritization.

Conclusions: Use of this CDS system was associated with significantly higher prescribing targeting most cardiovascular risk factors. These results highlight how displaying prioritized actions to reduce reversible CVD risk could improve risk management.

Trial registration: ClinicalTrials.gov, NCT03001713, https://clinicaltrials.gov/.

Keywords: Cardiology; Cardiovascular Diseases; Clinical Decision Support Systems; Clinical Trials; Community Health Centers; Decision-making; Health Equity; Medical Informatics; Practice Guideline; Primary Health Care; Quality Improvement.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Cardiovascular Diseases* / prevention & control
  • Decision Support Systems, Clinical*
  • Dyslipidemias*
  • Heart Disease Risk Factors
  • Humans
  • Risk Factors
  • Risk Reduction Behavior

Associated data

  • ClinicalTrials.gov/NCT03001713